{"entity":{"type":"insider","cik":"0001748392","url":"/insider/0001748392","json_url":"/insider/0001748392.json","name":"Williams Timothy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":13,"first":"2019-08-15","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Williams Timothy","source":"filing","n_filings":13,"first_seen":"2019-08-15","last_seen":"2026-03-04"}],"transactions":[{"id":6199471,"accession":"0001748392-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001748392-26-000002","line_url":"/filing/0001748392-26-000002#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42434.0,"shares_display":"42,434","price_per_share":8.2659,"price_display":"8.27","price_state":"stated","total_value":350755.2006,"total_display":"350,755.20","total_whole":"350,755","shares_owned_after":377450.0,"shares_owned_after_display":"377,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":3072465,"accession":"0000950170-24-027266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-027266","line_url":"/filing/0000950170-24-027266#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8941.0,"shares_display":"8,941","price_per_share":4.1825,"price_display":"4.18","price_state":"stated","total_value":37395.7325,"total_display":"37,395.73","total_whole":"37,396","shares_owned_after":196825.0,"shares_owned_after_display":"196,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":3072456,"accession":"0000950170-24-027266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-027266","line_url":"/filing/0000950170-24-027266#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8147.0,"shares_display":"8,147","price_per_share":4.4086,"price_display":"4.41","price_state":"stated","total_value":35916.8642,"total_display":"35,916.86","total_whole":"35,917","shares_owned_after":205766.0,"shares_owned_after_display":"205,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8372289,"accession":"0001209191-23-037326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037326","line_url":"/filing/0001209191-23-037326#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14600.0,"shares_display":"14,600","price_per_share":6.5585,"price_display":"6.56","price_state":"stated","total_value":95754.1,"total_display":"95,754.10","total_whole":"95,754","shares_owned_after":88913.0,"shares_owned_after_display":"88,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"},{"id":8249320,"accession":"0001209191-23-016464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-016464","line_url":"/filing/0001209191-23-016464#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8301.0,"shares_display":"8,301","price_per_share":6.2507,"price_display":"6.25","price_state":"stated","total_value":51887.0607,"total_display":"51,887.06","total_whole":"51,887","shares_owned_after":103513.0,"shares_owned_after_display":"103,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":8249317,"accession":"0001209191-23-016464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016464","line_url":"/filing/0001209191-23-016464#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8437.0,"shares_display":"8,437","price_per_share":6.2445,"price_display":"6.24","price_state":"stated","total_value":52684.8465,"total_display":"52,684.85","total_whole":"52,685","shares_owned_after":111814.0,"shares_owned_after_display":"111,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6107808,"accession":"0001209191-22-061673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-061673","line_url":"/filing/0001209191-22-061673#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":7.0087,"price_display":"7.01","price_state":"stated","total_value":56069.6,"total_display":"56,069.60","total_whole":"56,070","shares_owned_after":87551.0,"shares_owned_after_display":"87,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-16","scope":"insider"},{"id":6398677,"accession":"0001209191-22-046228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046228","line_url":"/filing/0001209191-22-046228","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8300.0,"shares_display":"8,300","price_per_share":10.301725072289157,"price_display":"10.30","price_state":"stated","total_value":85504.3181,"total_display":"85,504.32","total_whole":"85,504","shares_owned_after":95551.0,"shares_owned_after_display":"95,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider","n_lines":2},{"id":6668399,"accession":"0001209191-22-015160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015160","line_url":"/filing/0001209191-22-015160#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12060.0,"shares_display":"12,060","price_per_share":11.0928,"price_display":"11.09","price_state":"stated","total_value":133779.168,"total_display":"133,779.17","total_whole":"133,779","shares_owned_after":103851.0,"shares_owned_after_display":"103,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-02","scope":"insider"},{"id":4229635,"accession":"0001209191-21-051865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-051865","line_url":"/filing/0001209191-21-051865#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3715.0,"shares_display":"3,715","price_per_share":16.1477,"price_display":"16.15","price_state":"stated","total_value":59988.7055,"total_display":"59,988.71","total_whole":"59,989","shares_owned_after":83211.0,"shares_owned_after_display":"83,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider"},{"id":4224378,"accession":"0001209191-21-018651","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018651","line_url":"/filing/0001209191-21-018651","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5600.0,"shares_display":"5,600","price_per_share":17.85107142857143,"price_display":"17.85","price_state":"stated","total_value":99966.0,"total_display":"99,966.00","total_whole":"99,966","shares_owned_after":86926.0,"shares_owned_after_display":"86,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider","n_lines":2},{"id":4555046,"accession":"0001209191-21-017280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017280","line_url":"/filing/0001209191-21-017280#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7674.0,"shares_display":"7,674","price_per_share":18.5441,"price_display":"18.54","price_state":"stated","total_value":142307.4234,"total_display":"142,307.42","total_whole":"142,307","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider"},{"id":4555042,"accession":"0001209191-21-017280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017280","line_url":"/filing/0001209191-21-017280#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11856.0,"shares_display":"11,856","price_per_share":18.6018,"price_display":"18.60","price_state":"stated","total_value":220542.9408,"total_display":"220,542.94","total_whole":"220,543","shares_owned_after":100200.0,"shares_owned_after_display":"100,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2587261,"accession":"0001209191-20-046965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-046965","line_url":"/filing/0001209191-20-046965#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3684.0,"shares_display":"3,684","price_per_share":11.8149,"price_display":"11.81","price_state":"stated","total_value":43526.0916,"total_display":"43,526.09","total_whole":"43,526","shares_owned_after":79356.0,"shares_owned_after_display":"79,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-17","scope":"insider"},{"id":3311234,"accession":"0001209191-20-016210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016210","line_url":"/filing/0001209191-20-016210#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1237.0,"shares_display":"1,237","price_per_share":10.5124,"price_display":"10.51","price_state":"stated","total_value":13003.8388,"total_display":"13,003.84","total_whole":"13,004","shares_owned_after":83040.0,"shares_owned_after_display":"83,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-04","scope":"insider"},{"id":3311227,"accession":"0001209191-20-016210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-016210","line_url":"/filing/0001209191-20-016210#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3148.0,"shares_display":"3,148","price_per_share":10.3036,"price_display":"10.30","price_state":"stated","total_value":32435.7328,"total_display":"32,435.73","total_whole":"32,436","shares_owned_after":84277.0,"shares_owned_after_display":"84,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":8010060,"accession":"0001209191-19-046166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046166","line_url":"/filing/0001209191-19-046166#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001748392","owner_name":"Williams Timothy","owner_display_name":"Williams Timothy","owner_url":"/insider/0001748392","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2575.0,"shares_display":"2,575","price_per_share":14.691,"price_display":"14.69","price_state":"stated","total_value":37829.325,"total_display":"37,829.32","total_whole":"37,829","shares_owned_after":57425.0,"shares_owned_after_display":"57,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (SVP & General Counsel)","n_filings":13,"first_seen":"2019-08-15","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001748392","retrieved_at":"2026-08-24T00:07:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}